Highland Capital Management (Texas)’s Bio-Techne TECH Stock Holding History

Highland Capital Management (Texas)’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,000	Closed	-$363K	–	334
2017 Q3	$363K	Buy	12,000 +2,000	+20%	+$59.4K	0.02%	237
2017 Q2	$294K	Buy	+10,000	New	+$273K	0.01%	249
2017 Q1	–	Sell	-88,000	Closed	-$2.26M	–	321
2016 Q4	$2.26M	Sell	88,000 -174,000	-66%	-$4.57M	0.11%	138
2016 Q3	$7.17M	Buy	+262,000	New	+$7.2M	0.22%	97

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highland Capital Management (Texas)'s TECH Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of Bio-Techne (TECH) in Q4 2017, closing a stake of 12,000 shares — an estimated $363K sold.

Highland Capital Management (Texas) first reported a position in TECH in Q3 2016 and held it in 4 quarters. The position peaked at $7.17M in Q3 2016. 297 funds tracked by Wall St. Rank hold TECH as of Q4 2017.

Highland Capital Management (Texas) reported no remaining Bio-Techne position as of Q4 2017 after selling out during the quarter.
Highland Capital Management (Texas) sold 12,000 Bio-Techne shares in Q4 2017, an estimated $363K.
Highland Capital Management (Texas) first reported a position in Bio-Techne in Q3 2016 and held it in 4 quarters.
Highland Capital Management (Texas)'s Bio-Techne position peaked at $7.17M in Q3 2016.
297 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.